Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (£272m) spanning five years due to Washington's demand for confidential biological samples.
This rejection came to light after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative has since clarified that the United States was requesting health data for research and profit but was unwilling to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued talks to secure a deal agreeable to both sides so the nation's critical HIV programme can be sustained.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were raised about the security of citizens' medical information.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance openness and accountability.
Based on statements, 16 African countries have to date signed these new agreements, constituting over $18.3bn in new funding.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"In essence, our country would provide the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our population should a new pandemic emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks previously established through the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This system is intended to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage further discussions with our American counterparts on how subsequent co-operation could be arranged in a manner that honours the sovereignty and dignity of each country."
Health Experts Reaction
Medical experts said it understood the official position, but urged that negotiations should continue considering much of the country's Aids initiatives relied on foreign aid.
"In cases where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be resolved through detailed discussion and mutually agreed protections," the group said.
The situation emphasises the complex tensions between accepting crucial foreign assistance and protecting local interests in an ever more interconnected world.